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he homotrimeric DNA replication protein proliferat-
ing cell nuclear antigen (PCNA) is regulated by both
ubiquitylation and sumoylation. We study the ap-
pearance and the impact of these modiﬁcations on chro-
mosomal replication in frog egg extracts. 
 
Xenopus laevis
 
PCNA is modiﬁed on lysine 164 by sumoylation, mono-
ubiquitylation, and diubiquitylation. Sumoylation and
monoubiquitylation occur during the replication of undam-
aged DNA, whereas diubiquitylation occurs speciﬁcally in
response to DNA damage. When lysine 164 modiﬁcation
is prevented, replication fork movement through undam-
T
 
aged DNA slows down and DNA polymerase 
 
 
 
 fails to
associate with replicating chromatin. When sumoylation
alone is prevented, replication occurs normally and neither
monoubiquitylation nor sumoylation are required for the
replication of simple single-strand DNA templates. Our
ﬁndings expand the repertoire of functions for PCNA
ubiquitylation and sumoylation by elucidating a role for
these modiﬁcations during the replication of undamaged
DNA. Furthermore, they suggest that PCNA monoubiqui-
tylation serves as a molecular gas pedal that controls the
speed of replisome movement during S phase.
 
Introduction
 
One of the premier events of the cell cycle is the replication of
DNA in preparation for cell division. Proliferating cell nuclear
antigen (PCNA) was originally characterized as a protein that
localized to the nucleus of proliferating cells (Miyachi et al.,
1978). It has since been shown to be involved in a large number
of DNA metabolic processes, such as transcription, replication,
and repair (Shivji et al., 1992; Matsumoto et al., 1994; Waga et
al., 1994; Chuang et al., 1997; Jonsson et al., 1998; Tom et al.,
2000; Matsumoto, 2001; Hoege et al., 2002; Iida et al., 2002).
PCNA is loaded onto replicating DNA by replication factor C
and forms a homotrimeric ring that acts as a sliding clamp on
DNA (Burgers, 1991; Krishna et al., 1994; Kelman and
O’Donnell, 1995; Schurtenberger et al., 1998). Dozens of bind-
ing partners have been discovered for PCNA, and it is thought
that PCNA serves to tether these proteins to DNA to enhance
and localize their function (Kelman and Hurwitz, 1998; Maga
and Hubscher, 2003). One example of PCNA enhancing the
enzymatic function of a binding partner is the PCNA–DNA
polymerase 
 
 
 
 interaction. It has been shown that PCNA binds
DNA polymerase 
 
 
 
 and increases the processivity of the enzyme
(Prelich et al., 1987). Because of the wide range of processes
PCNA is involved in, it is clear that the binding of proteins to
PCNA must be controlled in both a temporal and spatial way.
One possible way to regulate the binding of proteins to PCNA
is through differential modification of the PCNA trimer. Previ-
ous studies have demonstrated that PCNA can be acetylated,
phosphorylated, ubiquitylated, and sumoylated (Prosperi et al.,
1993, 1994; Hoege et al., 2002; Naryzhny and Lee, 2004).
In yeast, PCNA is monoubiquitylated and polyubiquityl-
ated in response to DNA-damaging agents such as methane
methylsulfonate (MMS) and UV radiation (Hoege et al., 2002).
The ubiquitylation occurs on lysine 164 and is mediated by the
Rad6p ubiquitin E2 in conjunction with the Rad18p single-
strand DNA (ssDNA)–binding protein. Through genetic epistasis
analysis, a model was proposed in which PCNA ubiquitylation
was involved in lesion bypass during S phase to prevent repli-
cation forks from arresting at sites of DNA damage (Hoege et
al., 2002; Stelter and Ulrich, 2003; Haracska et al., 2004).
More specifically, monoubiquitylation was shown to be in the
same genetic pathway as DNA polymerase 
 
 
 
, a translesion
polymerase, and polyubiquitylation was demonstrated to be
epistatic to 
 
UBC13
 
, which is involved in an alternative path-
way of postreplication repair (Hoege et al., 2002; Stelter and
Ulrich, 2003; Haracska et al., 2004). The polyubiquitylation of
PCNA occurs via K63 linkage of ubiquitin monomers, which
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does not target the substrate for degradation as does the tradi-
tional K48-linked polyubiquitin chains.
PCNA is also monoubiquitylated in response to treatment
with DNA-damaging agents in mammalian cells (Kannouche
et al., 2004; Watanabe et al., 2004). PCNA ubiquitylation in
human cells is dependent on the human homologue of 
 
RAD18
 
and is required for the formation of DNA polymerase 
 
 
 
 subnu-
clear foci in response to DNA damage (Watanabe et al., 2004).
Kannouche et al. (2004) demonstrated that polymerase 
 
 
 
 binds
preferentially to monoubiquitylated PCNA. These data are
consistent with a role for monoubiquitylation of PCNA in
translesion synthesis in response to DNA damage. Only
monoubiquitylation has been observed in higher eukaryotes
(Kannouche et al., 2004; Watanabe et al., 2004).
The role of PCNA sumoylation, which until this study
has only been reported in budding yeast, is less clear. Sumoyla-
tion of PCNA also occurs on lysine 164 and has been geneti-
cally linked to the suppression of 
 
RAD52
 
 function, suggesting
that PCNA sumoylation may prevent unwanted and deleterious
recombination during DNA replication (Haracska et al., 2004).
This hypothesis was further strengthened by the observation
that sumoylated PCNA recruits the Srs2p helicase to DNA,
which acts to prevent recombination (Papouli et al., 2005;
Pfander et al., 2005). There is no clear Srs2p homologue in
higher eukaryotes, indicating that this function of sumoylated
PCNA may not be conserved.
To gain further insights into the regulation of PCNA
function via ubiquitylation and sumoylation in metazoans, we
have characterized PCNA modification during DNA replica-
tion in 
 
Xenopus laevis 
 
egg extracts. We find that PCNA is both
sumoylated and monoubiquitylated during normal S phase.
After DNA damage, PCNA is further modified by diubiquityl-
ation via a lysine 63 linkage on ubiquitin. The impact of elimi-
nation of PCNA modification on progression through S phase
is also examined.
 
Results
 
PCNA is monoubiquitylated and 
sumoylated during DNA replication
 
X. laevis 
 
egg extracts can be used to synchronously replicate
sperm chromatin and have proven essential to increasing our
understanding of the events that occur during DNA replication.
We first wanted to determine if PCNA underwent secondary
protein modifications during DNA synthesis in this cell-free
system. We prepared a crude extract from 
 
X. laevis
 
 eggs, added
sperm chromatin in the presence of an ATP-regeneration sys-
tem, and incubated it at room temperature. After the indicated
amounts of time, the chromatin was isolated from the extracts
by sequential centrifugation through two sucrose cushions and
resuspended in SDS sample buffer. The samples were separated
by PAGE and subjected to Western blotting analysis with an an-
tibody recognizing PCNA. Duplicate samples also contained
 
32
 
P-dATP. Samples were collected at the indicated times, and
DNA replication was measured as described in Materials and
methods. As seen in Fig. 1 A, two slower migrating bands are
detected at 30 and 60 min, coincident with the majority of
nucleotide incorporation (Fig. 1, A and B). To further investi-
gate the dependence of these bands on DNA replication we re-
peated the chromatin spin down, but in the presence or absence
of recombinant GST-tagged geminin. Geminin inhibits the
function of the essential replication factor Cdt1 and thereby
blocks replication fork assembly and subsequent DNA replica-
tion. We also examined the unbound fraction of these chromatin
isolations to assess whether or not the modification of PCNA
was limited to the chromatin-bound PCNA. Fig. 1 C clearly
demonstrates that only chromatin-bound PCNA exhibits slower
migrating versions of PCNA. Also, it is clear that inhibition of
replication by the addition of GST-tagged geminin prevents the
appearance of the slower migrating forms of PCNA.
To determine if these bands corresponded to either ubiq-
uitylated or sumoylated PCNA, we combined freshly prepared
crude extract with 0.5 
 
 
 
g/
 
 
 
L of recombinant histidine (His)-
tagged ubiquitin, GST-tagged small ubiquitin-related modifier
(SUMO) 1, or GST-tagged SUMO2. Sperm chromatin and
an ATP-regeneration mix was added to the extract, and the
reactions were incubated at room temperature for 40 min.
Figure 1. PCNA undergoes secondary modifications during DNA replication.
(A) Undamaged sperm chromatin was isolated from X. laevis egg extract
after 30, 60, 90, or 120 min. The associated proteins were analyzed by
Western blotting using an antibody recognizing PCNA. (B) Duplicate sam-
ples from A contained 
32P-dATP and DNA replication was measured as
described in Materials and methods. (C) Sperm chromatin was incubated
in X. laevis egg extract for 30 min with or without 250  M of recombinant
GST-geminin (rGeminin). The chromatin was isolated and resuspended in
SDS sample buffer. A sample was also collected from the supernatant
fraction to analyze the unbound fraction. 
SUMOYLATION AND UBIQUITYLATION OF PCNA • LEACH AND MICHAEL
 
949
 
The chromatin was then purified and the resulting samples an-
alyzed, as in Fig. 1 A. If one of the slower migrating bands was
the result of ubiquitin conjugation we would expect that band
to undergo an additional shift of 
 
 
 
1 kD as a result of the His-
tag on the recombinant ubiquitin. Likewise, if one of the bands
was the result of SUMO conjugation we would expect that
band to undergo an additional shift of 25 kD, corresponding to
the GST tag on the recombinant SUMO. As seen in Fig. 2 A,
when His-tagged ubiquitin (His-Ub) is added, the lower of
the two bands undergoes an additional shift. When either
GST-tagged SUMO1 (GST-SUMO1) or GST-tagged SUMO2
(GST-SUMO2) is added, the upper band undergoes an addi-
tional shift. Interestingly, despite adding equal amounts of
GST-SUMO1 or GST-SUMO2 we observe that the conjuga-
tion of GST-SUMO1 is much more efficient. We conclude that
PCNA undergoes both monoubiquitylation and sumoylation
during normal DNA replication in 
 
X. laevis
 
 egg extracts.
We wanted to verify that these modifications were depen-
dent on lysine 164, as is the case in yeast and mammalian cells
(Hoege et al., 2002). We repeated the aforementioned chroma-
tin spin down experiments, but added recombinant PCNA
(rPCNA) with both a T7 and a 6-His tag to a concentration of
0.2 
 
 
 
g/
 
 
 
L. This recombinant protein was either wild type
(rWT) or mutated to contain an arginine at position 164 instead
of lysine (rK164R). After chromatin isolation, the samples
were subjected to SDS-PAGE and Western blotting with either
the PCNA antibody or an antibody against the T7 tag to specif-
ically recognize the rPCNA. When these samples are blotted
with an antibody recognizing PCNA (Fig. 2 B, top), both
sumoylation and ubiquitylation of endogenous and exogenous
PCNA can be seen. In the second lane, all of the bands exist as
doublets because of the increased size of the recombinant T7-
tagged PCNA protein. When a T7 antibody is used it becomes
very clear that the mutation of lysine 164 results in the abolish-
ment of PCNA modifications by either SUMO or ubiquitin
(Fig. 2 B, bottom). We conclude that both monoubiquitylation
and sumoylation occur on lysine 164 of 
 
X. laevis
 
 PCNA. This
experiment also shows that PCNA modification is not required
for loading PCNA onto chromatin because the mutant PCNA
associates with chromatin to the same extent as wild type, if not
slightly better.
 
PCNA modification is not required for 
ssDNA replication
 
Previously, it had been shown that PCNA can be removed from
 
X. laevis
 
 egg extracts using a peptide derived from the p21 pro-
tein (Mattock et al., 2001). We used this peptide to deplete
PCNA from extracts, as shown in Fig. 3 A. Unfortunately, this
extract was unable to replicate sperm chromatin after the addi-
tion of recombinant untagged PCNA (not depicted). This is con-
sistent with published data and may be the result of co-depletion
of some other factor (Mattock et al., 2001). The PCNA-depleted
extract is unable to replicate single-stranded M13 DNA, but
the addition of rPCNA restores the activity of the extract, as
shown previously. Interestingly, the addition of mutant PCNA
(rK164R) also restores the activity of the extract, demonstrating
that modification of PCNA is not required for the replication of
simple ssDNA templates (Fig. 3 B).
Figure 2. PCNA is monoubiquitylated and sumoylated during DNA
replication. (A) X. laevis egg extract was incubated with sperm chromatin
and either buffer, 0.5  g/ L His-tagged ubiquitin, 0.5  g/ L GST-
SUMO1, or 0.5  g/ L GST-SUMO2. Chromatin was isolated and ana-
lyzed by Western blotting with an antibody recognizing PCNA. The bottom
blot shows a Western blot, using an antibody recognizing GST, of the
sample before chromatin isolation. (B) X. laevis egg extract was incubated
with sperm chromatin and either buffer, 200 ng/ L T7-PCNA (rWT), or
200 ng/ L T7-PCNA (rK164R). Chromatin was isolated and analyzed by
immunoblotting with an antibody recognizing either PCNA or the T7 tag.
Figure 3. PCNA modification is not required
for M13 replication. (A) p21-peptide beads
were used to deplete PCNA from X. laevis
egg extract as described in Materials and
methods, and the resulting extracts were an-
alyzed by SDS-PAGE and Western blotting
using an antibody recognizing PCNA. (B)
Either mock- or peptide-depleted extract was
incubated with M13 DNA for 30 min. The
peptide-depleted extract was supplemented
with buffer, 0.2  g/ L PCNA (wild type), or
0.2   g/ L PCNA (K164R). The samples
were then analyzed for DNA replication as
described in Materials and methods. 
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PCNA sumoylation is not required for 
chromatin replication
 
We hypothesized that the sumoylation of PCNA during S phase
might play a role in chromatin replication. To test this we used
a dominant-negative version of Ubc9 (Ubc9-DN), the only
known E2 enzyme involved in the conjugation of SUMO to
substrate proteins. As shown in Fig. 4 A, the addition of recom-
binant Ubc9-DN results in the disappearance of SUMO-modified
PCNA. We then tested the effect of this dominant-negative
protein on DNA replication. We combined 
 
X. laevis
 
 crude ex-
tract with 0.8 
 
 
 
g/
 
 
 
L of either buffer or Ubc9-DN. After a short
incubation on ice, an ATP regeneration system, 
 
32
 
P-dATP, and
sperm chromatin were added. Samples were collected after 30
and 60 min, and DNA replication was measured as described in
Materials and methods. Fig. 4 B clearly shows that, despite the
ability of Ubc9-DN to prevent sumoylation of PCNA, it has no
effect on DNA replication. The Ubc9-DN will inhibit the
sumoylation of all proteins in the extract, but because there is
no impact on replication we can conclude that sumoylation is
not required for DNA replication and, more specifically, that
PCNA sumoylation is not required. These data are consistent
with a previous paper showing that Ubc9-DN does not affect
replication in 
 
X. laevis
 
 egg extracts (Azuma et al., 2003).
 
PCNA lysine 164 modification is 
required for proper replication fork 
progression
 
Despite repeated attempts using a variety of strategies, we could
not selectively eliminate PCNA monoubiquitylation while leav-
ing sumoylation intact. However, we have shown that sumoyla-
tion is not important for DNA replication (Fig. 4). To get at a
possible function for monoubiquitylation in replication, we
determined the effect of eliminating lysine 164 modification on
chromosomal replication. To do this we added either untagged
wild-type or mutant (K164R) rPCNA protein to extracts and an-
alyzed the effect on both replication and PCNA modification in
the extract. As shown in Fig. 5 A, addition of the mutant PCNA
results in a decrease in the amount of modified PCNA bound to
chromatin. This is presumably attributable to the mutant recom-
binant protein outcompeting the endogenous PCNA for binding
sites on chromatin. In Fig. 5 B, it is clear that the addition of this
mutant PCNA inhibits replication at both the 30 and 60 min
time points. We conclude that modification of PCNA lysine 164
is important for efficient replication. This is likely the result of
the loss of monoubiquitylation of PCNA because the Ubc9-DN
protein had no inhibitory effect on replication, but did eliminate
sumoylation of lysine 164. It is also possible that PCNA
monoubiquitylation and sumoylation act redundantly during
replication, as our experiment does not rule this out. 
To investigate what step in replication was being affected
by the loss of lysine 164 modifications, we used alkaline aga-
rose gels to determine the length of the nascent strands of DNA
when either wild-type or mutant PCNA was added to the extract.
Replication assays were performed under normal conditions
and samples were then treated with a high pH buffer to separate
the strands. Samples were run on a gel under basic conditions
and dried, and signal was measured with a phosphoimager
(Fig. 6 A). Using National Institutes of Health Image software,
a line was placed in the center of each lane and the pixel inten-
sity at each point along the line was measured. The pixel in-
tensity at a point is an indication of how many molecules of
that length were generated during replication. By comparing
the gel to a DNA ladder we were able to plot pixel intensity ver-
sus DNA fragment size (Fig. 6 B). As shown in Fig. 6 (A and B),
the addition of rPCNA (K164R) to the extracts reduces the
length of nascent DNA strands relative to rPCNA wild type.
One possible explanation of this result is that in the presence
Figure 4. Sumoylation of PCNA is not required for sperm chromatin repli-
cation. (A) X. laevis egg extract was supplemented with either buffer or 5
 g/ L GST-Ubc9 dominant-negative protein (Ubc9-DN). Sperm chromatin
was incubated in these extracts for 30 min and isolated. The resulting sam-
ples were subjected to SDS-PAGE and Western blotting using an antibody
recognizing PCNA. (B) Duplicate samples containing 
32P-dATP were used to
calculate the amount of DNA replication occurring in these samples after 30
and 60 min as described in Materials and methods. The average of three
independent experiments is shown with error bars representing the SEM.
Figure 5. Ubiquitylation of PCNA facilitates sperm chromatin replication.
(A) Sperm chromatin was incubated in X. laevis egg extract supplemented
with buffer, 0.2  g PCNA (wild type), or 0.2  g PCNA (K164R) for 45 min.
The chromatin was then isolated and analyzed by SDS-PAGE followed by
Western blotting with an antibody recognizing PCNA. (B) Duplicate sam-
ples containing 
32P-dATP were used to measure DNA replication after 30
and 60 min as described in Materials and methods. The average of three
independent experiments is shown with error bars representing the SEM.  
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of rPCNA (K164R) some replication forks are abandoned,
whereas others progress normally. To test this hypothesis we
repeated this experiment but added 1 mM of cold dATP after
25 min, which allowed us to watch the progression of only
those replication forks that had already initiated DNA synthe-
sis. As seen in Fig. 6 C, it is clear that high molecular mass
strands are formed at a slower rate in the presence of K164R,
indicating that K164R PCNA does not induce a significant
amount of irreversible fork abandonment. We conclude that
PCNA modification is required for replication elongation to
occur with maximal efficiency on undamaged chromosomes.
The fact that modification of lysine 164 is not required for rep-
lication of ssDNA, but facilitates chromatin replication, sug-
gests that monoubiquitylation of PCNA may play a role in un-
winding the DNA or in relaxing the chromatin structure to
allow for proper replication fork progression.
 
PCNA modification impacts polymerase 
 
 
 
 
binding to chromatin
 
In an attempt to determine the cause of the slow fork progres-
sion resulting from a knockdown of PCNA lysine 164 modifi-
cation in the extracts, we examined the binding of polymerase
 
 
 
 to chromatin under these conditions. As can be seen in Fig. 7,
the addition of mutant PCNA to the extract resulted in the elim-
ination of lysine 164 modifications, as expected. In extracts
containing this mutant, we observed a significant decrease in
polymerase 
 
 
 
 bound to chromatin when compared with the ad-
dition of wild-type PCNA. In contrast, we did not detect any
effect of the mutant PCNA on the loading of the prereplication
complex component Orc2, the ssDNA-binding protein replica-
tion protein A, or DNA polymerase 
 
 
 
 (p70 subunit) to chromatin.
We conclude that lysine 164 modification of PCNA is required
for both efficient chromosomal replication and for stable asso-
ciation of polymerase 
 
 
 
 with replicating chromatin.
 
PCNA is polyubiquitylated after 
DNA damage
 
The results presented thus far indicate that PCNA is monoubiq-
uitylated and sumoylated during a normal, uninterrupted S
phase and that monoubiquitylation is required for efficient
replication fork progression. Thus, these findings represent a
departure from studies in yeast and human cells where mono-
ubiquitylation is only readily observed after DNA damage
(Introduction). Therefore, it was important to determine the
status of PCNA in our system after DNA damage. For this we
used sperm chromatin that had been damaged by exposure to
UV light. This chromatin was incubated in egg extract and iso-
lated, and PCNA was examined by immunoblotting. The inclu-
sion of damaged chromatin resulted in a third slowly migrating
band on the PCNA blot, suggesting that PCNA had undergone
an additional modification in response to the damaged DNA,
and all three slower migrating bands persisted throughout the
entire time course of the experiment (Fig. 8 A). This persis-
tence is consistent with the observation that damaged chroma-
tin requires more time to replicate and that, even at 120 min,
nucleotide was still being incorporated (Fig. 8 B). To determine
if this banding pattern was unique to UV-damaged chromatin,
we repeated the chromatin spin down using UV-damaged
Figure 6. Loss of PCNA ubiquitylation slows replication fork progression.
(A) Sperm chromatin was incubated in X. laevis egg extract containing
either 0.2  g/ L PCNA (wild type) or 0.2  g/ L PCNA (K164R). Aliquots
were removed after 25, 30, 35, 40, 45, and 50 min and prepared for
alkaline agarose gel analysis as described in Materials and methods. (B)
Fragment lengths were calculated by comparison to a DNA ladder and
plotted against pixel intensity obtained with National Institutes of Health
Image software. (C) Sperm chromatin was incubated in X. laevis egg ex-
tract containing either 0.2  g/ L PCNA (wild type) or 0.2  g/ L PCNA
(K164R). Cold dATP was added after 25 min. Aliquots were removed after
25, 30, 35, 40, 45, and 50 min and prepared for alkaline agarose gel
analysis as described in Materials and methods.
Figure 7. Loss of PCNA modification inter-
feres with chromatin binding of DNA poly-
merase  . Sperm chromatin was incubated
in  X. laevis egg extract containing either
buffer,  0.2   g/ L PCNA (wild type), or
0.2  g/ L PCNA (K164R). After 40 min
the chromatin was isolated and resus-
pended in SDS sample buffer. The samples
were then analyzed by SDS-PAGE and
Western blotting with antibodies recognizing
the indicated proteins. 
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chromatin or MMS-damaged chromatin. We also tested undam-
aged chromatin in the presence of 100 
 
 
 
g/ml aphidicolin. As
seen in Fig. 8 C, MMS-damaged chromatin exhibits the same
banding pattern as UV-damaged chromatin. Aphidicolin treat-
ment leads to an increase in the middle band, and there is no
detectable PCNA sumoylation. To determine if the broad band
induced  by aphidicolin treatment merely masked sumoylated
PCNA, we repeated the experiment in the presence of GST-
SUMO1, which causes a large shift in sumoylated PCNA, but no
band appeared, indicating that aphidicolin treatment prevents
sumoylation of PCNA (not depicted). Importantly, neither UV,
MMS, or aphidicolin treatment resulted in a significant increase
in the appearance of the monoubiquitylated form of PCNA.
To determine if this new modification was dependent on
lysine 164 of PCNA, we repeated the experiment shown in
Fig. 2 B, except that all of the extracts contained 100 
 
 
 
g/ml
aphidicolin. As can be seen in Fig. 8 D, the damage- and aphid-
icolin-induced modification of PCNA, is dependent on lysine
164, suggesting that it may be the result of polyubiquitylation.
To determine if the band induced by damaged chromatin or
aphidicolin treatment was diubiquitylated PCNA we added un-
damaged chromatin to an extract containing 100 
 
 
 
g/ml aphidi-
colin, isolated the chromatin, and analyzed the samples as de-
scribed for Fig. 2 B. These extracts contained buffer, 0.5 
 
 
 
g/
 
 
 
L
of wild-type His-tagged ubiquitin, or 0.5 
 
 
 
g/
 
 
 
L His-tagged
ubiquitin containing a lysine to arginine mutation at position 63.
Fig. 8 E, clearly shows that the lower band is a monoubiquityl-
ated form of PCNA because nonchain-forming mutants of
ubiquitin (K63R) behaved identically to recombinant wild-type
ubiquitin. We can conclude that the damage- and aphidicolin-
induced modification of PCNA is a result of diubiquitylation of
PCNA because the K63R ubiquitin mutant causes a shift in the
lower band (because of the His tag) and prevents the induction
of the second band. Furthermore, this diubiquitylation appears
to represent the “damage mark” on 
 
X. laevis
 
 PCNA, as neither
sumoylation nor monoubiquitylation is noticeably increased after
DNA damage. Based on these data, we conclude that 
 
X. laevis
 
PCNA is sumoylated and monoubiquitylated in response to
normal DNA replication and that it is diubiquitylated when
replication forks stall at sites of DNA damage.
 
Discussion
 
PCNA is monoubiquitylated and 
sumoylated on lysine 164 during normal 
S phase
 
In this study, we examined modification of PCNA by mono-
ubiquitylation and sumoylation. Both of these modifications
occur exclusively on the highly conserved lysine 164 residue.
We found that sumoylation is mediated by Ubc9, but we do not
yet know which ubiquitin pathway components are responsible
for monoubiquitylation. In yeast, the Rad6p E2 ubiquitylates
PCNA. We tested the effect of the addition of a putative domi-
nant-negative 
 
X. laevis
 
 Rad6 protein on PCNA monoubiquityl-
ation and found that monoubiquitylation was not attenuated by
the presence of this mutant (unpublished data). Thus, more
work will be required to identify the factors that are required
for PCNA ubiquitylation. The conditions for modification of
PCNA were also determined. We found that both monoubiqui-
tylation and sumoylation require replication fork assembly, as
these modifications are lost when the replication inhibitor gem-
inin is included in the extract and the modifications are found
exclusively in the chromatin-bound fraction of PCNA (Fig. 1 C).
Thus, PCNA is modified on lysine 164 as a function of being
loaded onto the replication fork.
In this paper, we showed for the first time that PCNA is
sumoylated during DNA replication in metazoans. As is the
case in yeast, sumoylation of PCNA is not required for DNA
replication in 
 
X. laevis
 
. Recent work in yeast has yielded a
model in which sumoylated PCNA prevents recombination by
binding the Srs2 protein, a member of the RecQ family of heli-
cases (Haracska et al., 2004; Papouli et al., 2005; Pfander et al.,
2005). Although metazoan genomes contain multiple members
of the RecQ helicase family it is unclear which of these is the
functional homologue of Srs2p, and our preliminary findings
indicate that loss of PCNA sumoylation does not affect associ-
ation of the Werner’s or Bloom’s RecQ family helicases with
Figure 8. DNA damage induces polyubiquitylation of PCNA. (A) UV-
damaged sperm chromatin was isolated from X. laevis egg extract after
30, 60, 90, or 120 min. The associated proteins were analyzed by Western
blotting using an antibody recognizing PCNA. The control portions of this
experiment are reproduced from Fig. 1 A to facilitate comparison. (B)
Duplicate samples from A contained 
32P-dATP and DNA replication was
measured as described in Materials and methods. Closed circles represent
undamaged chromatin and open squares represent UV-damaged chromatin.
(C) Undamaged chromatin, MMS-damaged chromatin, or UV-damaged
chromatin was isolated from X. laevis egg extract after 45 min. Aphidicolin
was added to 100  g/ml at t    10 min to the extract incubated with un-
damaged chromatin. The associated proteins were analyzed by Western
blotting using an antibody recognizing PCNA. (D) X. laevis egg extract,
preincubated with 100  g/ml aphidicolin, was incubated with sperm
chromatin and either buffer, 0.2  g/ L T7-PCNA (rWT), or 0.2  g/ L
T7-PCNA (rK164R). Chromatin was isolated and analyzed by immuno-
blotting with an antibody recognizing either PCNA or the T7 tag. (E) X. laevis
egg extract was preincubated with 100  g/ml aphidicolin. Undamaged
sperm chromatin was incubated in this extract which also contained buffer,
0.5   g/ L His-tagged ubiquitin, or 0.5  g/ L His-tagged ubiquitin
(K63R). Chromatin was isolated and the bound proteins were analyzed by
Western blotting with an antibody recognizing PCNA.SUMOYLATION AND UBIQUITYLATION OF PCNA • LEACH AND MICHAEL 953
chromatin in egg extracts (unpublished data). We were unable
to detect PCNA sumoylation in either mammalian or X. laevis
tissue culture cells, which raises the possibility that this modifi-
cation is specific for embryonic cell cycles in metazoans.
Monoubiquitylation and DNA replication
The most important finding presented in this study is that
monoubiquitylation of PCNA is required for proper fork pro-
gression and the abolishment of the ubiquitylation of PCNA
disturbs polymerase   association with chromatin. More ex-
periments are required to determine whether the decreased
polymerase   binding is a result of or a cause of the slowed fork
progression. It is interesting to note that PCNA modification has
already been shown to alter the ability of PCNA to bind DNA
polymerases. For example, DNA polymerase   prefers to inter-
act with monoubiquitylated PCNA (Kannouche et al., 2004).
One possible explanation of our data is that DNA polymerase  
prefers to bind to monoubiquitylated PCNA in X. laevis egg ex-
tracts. Because the modification of PCNA is not required for ss-
DNA synthesis it is reasonable to hypothesize that PCNA ubiq-
uitylation may act in assisting the unwinding of the DNA strands
or in the restructuring of local chromatin structure. Consistent
with this, we note that replication protein A does not accumulate
on chromatin in extracts containing the PCNA K164R mutant as
compared with wild type (Fig. 7). This indicates that excess ss-
DNA is not being generated by the mutant, despite its ability to
attenuate DNA replication, and we have observed that the repli-
cation slowdown caused by the mutant does not activate a repli-
cation checkpoint response (unpublished data). Together these
observations indicate that PCNA ubiquitylation can control the
rate of fork progression in a manner that couples DNA synthesis
to DNA unwinding. The challenge for future studies will be to
determine how this coupling occurs.
DNA damage-induced diubiquitylation of 
PCNA and the interspecies plasticity of 
PCNA modification during chromosome 
metabolism
Our data demonstrate that X. laevis PCNA is diubiquitylated
when replication forks stall. At present, we do not know the
function of this modification, and we are currently investigat-
ing this important issue. Interestingly, we find that diubiquityl-
ation is the only modification that is affected by DNA damage,
as damage does not noticeably alter either sumoylation or
monoubiquitylation. Therefore, this finding strengthens the
conclusion that in X. laevis the sumoylation and monoubuiqityl-
ation of PCNA occurs during normal DNA replication and not
in response to low levels of damage that may be present in our
sperm chromatin preparations. The finding that DNA damage
induces only diubiquitylation of PCNA in X. laevis demon-
strates a surprisingly high degree of plasticity from species to
species in PCNA modifications. For example, in yeast, sumoy-
lation is observed during a normal S phase, whereas both
mono- and polyubiquitylation occur after DNA damage. In hu-
man cells, neither sumoylation nor polyubiquitylation have
been observed under any conditions, and monoubiquitylation is
strongly induced by DNA damage. And, as we have shown, in
X. laevis both sumoylation and monoubiquitylation occur dur-
ing normal S phase, whereas diubiquitylation is reserved for
the DNA damage response. Although some of these differences
may be attributable to the different methodologies used to track
PCNA modifications, others are likely to reflect specialized
functions for the modifications. A major challenge for future
studies will be to determine these functions so that this apparent
plasticity can be understood.
Materials and methods
Preparation of X. laevis egg extracts
Preparation of X. laevis egg extracts and preparation of sperm chromatin
were performed according to Walter and Newport (1999). To generate
damaged chromatin, purified chromatin was exposed to 100 mM MMS
or 100  Joules/m
2 of UV light.
Expression and purification of recombinant proteins
The X. laevis complementary DNA encoding PCNA was cloned into both
the pET28 and pET3 vectors (Novagen). The X. laevis complementary
DNA for Ubc9 was cloned into pGEX4T1 (GE Healthcare). For purifica-
tion of His6-tagged PCNA, BL21 cells transformed with the appropriate
plasmid were induced with 1 mM IPTG for 6 h. The cells were collected by
centrifugation at 4,100 rpm for 20 min at 4 C. Pellets were washed twice
with 50 mL PBS, and the resulting pellets were resuspended in 15 mL TEN
Buffer (50 mM Tris-HCl, pH 7.5, 0.5 mM EDTA, and 0.3 M NaCl) and
10 mL PBS. Lysozyme was added to a final concentration of 1 mg/ml,
and the suspension was incubated on ice for 15 min. NP-40 was added
to a final concentration of 0.2% (vol/vol) and the suspension was incu-
bated for an additional 10 min on ice. The sample was then frozen in
liquid nitrogen and stored at  80 C for at least 1 h. After the pellet was
thawed, the sample was sonicated three times at 50% power for 30 s
each using 1-s pulses. The extract was then centrifuged at 15,000 g for
20 min, and the supernatant was transferred to a 50-ml conical tube con-
taining 2 ml of either Ni-NTA beads (QIAGEN) or glutathione beads (GE
Healthcare) depending on the protein tag. The suspension was rotated at
4 C for 1 h and then poured into a column. The beads were washed ex-
tensively with either Nickel washing solution (20 mM Imidazole, pH 7, 20
mM KPi, pH 7, and 0.5 M NaCl) or PBS. His-tagged proteins were eluted
with 5 ml of Nickel elution solution (0.5 M Imidazole, pH 7, 20 mM KPi,
pH 7, and 0.5 M NaCl) and 0.5-mL fractions were collected. GST-tagged
proteins were eluted in a similar manner using GST elution solution (10 mM
of reduced glutathione and 50 mM Tris-HCl, pH 7.5). Fractions containing
protein were pooled and dialyzed with 50 mM MOPS-NaOH, pH 7.5, for
16 h and flash frozen in aliquots.
Purification of untagged PCNA pET3-PCNA was performed as
previously described with the phosphocellulose column replaced by a
phenyl–Sepharose column (Hubscher et al., 1999).
Chromatin spin downs
50   L of fresh extract was incubated with sperm chromatin at 2,000
sperm/ L for 40 min, unless otherwise stated. These reactions were mixed
every 10 min. 200  L ELB (0.25 M sucrose, 1 mM DTT, 2.5 mM MgCl2,
50 mM KCl, and 10 mM Hepes-KOH, pH 7.7) was added and the result-
ing mixture was layered onto a 1-mL sucrose cushion (0.9 M sucrose in
1  ELB salts (2.5 mM MgCl2, 50 mM KCl, and 10 mM Hepes-KOH, pH
7.7). The samples were centrifuged at 11,000 rpm for 2 min at 4 C. All
but 100  L of the sample was aspirated, and an additional 50  L was
removed using a P200 gel-loading tip (VWR). The pellet was then resus-
pended in 200  l ELB containing 0.6% Triton X-100, layered on top of
another 1-mL sucrose cushion, and centrifuged as before. After aspirating
all but 100  L, an additional 90  L was removed with a P200 gel-loading
tip. The resulting pellet was resuspended in 50  L SDS sample buffer.
The samples were boiled before analysis by Western blotting.
DNA replication
To measure DNA replication, 50  l of fresh extract was preincubated on
ice for 10 min with the treatments indicated in the figure legends. Sperm
chromatin or M13 plasmid was then added to the extract to a final con-
centration of 2,000 sperm/ L or 2 ng/ L, respectively. 5  Ci 
32P-dATP
was added to the extract and the reactions were incubated at room tem-
perature. At the specified times, 3  l of the reaction was removed andJCB • VOLUME 171 • NUMBER 6 • 2005 954
combined with 7  L of stop mix (6 mM EDTA, 0.13% phosphoric acid,
10% Ficoll, 5% SDS, 0.2% Bromphenol blue, and 80 mM Tris, pH 8). Pro-
teinase K was then added to a final concentration of 2  g/ L and the
samples were incubated for 1 h at 37 C. Samples were then electropho-
resed on a 0.8% (wt/vol) agarose/Tris-Borate EDTA gel, after which the
gel was dried and analyzed by a phosphoimager with ImageQuant soft-
ware (GE Healthcare).
PCNA depletion
A peptide from p21 (CKRRQTSMTDFYHHSKRRAIAS) was obtained from
Invitrogen. The peptide was conjugated to Amino-link beads (Pierce
Chemical Co.) following the manufacturer’s instructions and at a concen-
tration of 2 mg of peptide per milliliter of beads. For extract depletion,
214  L of crude X. laevis egg extract was added to 100  l of peptide
beads or control beads and incubated for 1 h on ice. The reaction was
mixed every 10 min, alternating resuspension with stirring. The mixture
was centrifuged at 10,000 rpm at 4 C for 2 min and the supernatant was
transferred to a new Eppendorf tube containing 100  L of peptide beads
or control beads. The 1-h incubation was repeated and the resulting super-
natant was used to measure replication as described in DNA replication.
Alkaline agarose gels
Replication assays were performed exactly as described above in DNA
replication, except that 5  L of extract was removed and added to 500  L
of ice-cold buffer A (5 mm EDTA, 20 mM Hepes-KOH, pH 7.6, and 50
mM NaCl) containing 0.5 mM spermine and 0.5 mM spermidine. Sam-
ples were stored on ice until all time points had been collected. Samples
were then centrifuged for 5 min at 14,000 rpm at 4 C. The supernatant
was removed and the pellets were resuspended in 50  L buffer A contain-
ing 0.5% SDS and 0.5 mg/ml proteinase K. Samples were incubated at
37 C for 1 h and phenol/chloroform extracted. The aqueous layer was
subjected to ethanol precipitation using 40  g of carrier RNA, and the re-
sulting DNA pellet was resuspended in 20  L of alkaline loading buffer
(300 mM NaOH, 6 mM EDTA, 18% Ficoll, 0.15% Bromcresol blue, and
0.25% xylene cyanol FF). Samples were run on a 0.8% (wt/vol) agarose
gel/50 mM NaCl/1 mM EDTA. The gel was equilibrated in alkaline run-
ning buffer (1 mM EDTA and 30 mM NaOH) for 1 h before the loading of
the samples. The gel was run for 5 h at 3 V/cm. The gel was then dried
and analyzed as described for replication assays.
This work was supported by National Research Service Award GM071231
from the National Institutes of General Medical Sciences (NIGMS), National
Institutes of Health, to C.A. Leach and by research grant R01GM67735 from
the NIGMS, National Institutes of Health, to W.M. Michael.
Submitted: 15 August 2005
Accepted: 8 November 2005
References
Azuma, Y., A. Arnaoutov, and M. Dasso. 2003. SUMO-2/3 regulates topo-
isomerase II in mitosis. J. Cell Biol. 163:477–487.
Burgers, P.M. 1991. Saccharomyces cerevisiae replication factor C. II. For-
mation and activity of complexes with the proliferating cell nuclear
antigen and with DNA polymerases delta and epsilon. J. Biol. Chem.
266:22698–22706.
Chuang, L.S., H.I. Ian, T.W. Koh, H.H. Ng, G. Xu, and B.F. Li. 1997. Human
DNA-(cytosine-5) methyltransferase-PCNA complex as a target for
p21WAF1. Science. 277:1996–2000.
Haracska, L., C.A. Torres-Ramos, R.E. Johnson, S. Prakash, and L. Prakash.
2004. Opposing effects of ubiquitin conjugation and SUMO modifica-
tion of PCNA on replicational bypass of DNA lesions in Saccharomyces
cerevisiae. Mol. Cell. Biol. 24:4267–4274.
Hoege, C., B. Pfander, G.L. Moldovan, G. Pyrowolakis, and S. Jentsch. 2002.
RAD6-dependent DNA repair is linked to modification of PCNA by
ubiquitin and SUMO. Nature. 419:135–141.
Hubscher, U., R. Mossi, E. Ferrari, M. Stucki, and Z.O. Jonsson. 1999. Func-
tional analysis of DNA replication accessory proteins. In  Eukaryotic
DNA Replication: A Practical Approach. Sue Cotterill, editor. Oxford
University Press. 119–137.
Iida, T., I. Suetake, S. Tajima, H. Morioka, S. Ohta, C. Obuse, and T. Tsurimoto.
2002. PCNA clamp facilitates action of DNA cytosine methyltransferase
1 on hemimethylated DNA. Genes Cells. 7:997–1007.
Jonsson, Z.O., R. Hindges, and U. Hubscher. 1998. Regulation of DNA replica-
tion and repair proteins through interaction with the front side of prolif-
erating cell nuclear antigen. EMBO J. 17:2412–2425.
Kannouche, P.L., J. Wing, and A.R. Lehmann. 2004. Interaction of human
DNA polymerase eta with monoubiquitinated PCNA: a possible mecha-
nism for the polymerase switch in response to DNA damage. Mol. Cell.
14:491–500.
Kelman, Z., and M. O’Donnell. 1995. Structural and functional similarities of
prokaryotic and eukaryotic DNA polymerase sliding clamps. Nucleic
Acids Res. 23:3613–3620.
Kelman, Z., and J. Hurwitz. 1998. Protein-PCNA interactions: a DNA-scanning
mechanism? Trends Biochem. Sci. 23:236–238.
Krishna, T.S., X.P. Kong, S. Gary, P.M. Burgers, and J. Kuriyan. 1994. Crystal
structure of the eukaryotic DNA polymerase processivity factor PCNA.
Cell. 79:1233–1243.
Maga, G., and U. Hubscher. 2003. Proliferating cell nuclear antigen (PCNA): a
dancer with many partners. J. Cell Sci. 116:3051–3060.
Matsumoto, Y. 2001. Molecular mechanism of PCNA-dependent base excision
repair. Prog. Nucleic Acid Res. Mol. Biol. 68:129–138.
Matsumoto, Y., K. Kim, and D.F. Bogenhagen. 1994. Proliferating cell nuclear
antigen-dependent abasic site repair in Xenopus laevis oocytes: an alterna-
tive pathway of base excision DNA repair. Mol. Cell. Biol. 14:6187–6197.
Mattock, H., P. Jares, D.I. Zheleva, D.P. Lane, E. Warbrick, and J.J. Blow.
2001. Use of peptides from p21 (Waf1/Cip1) to investigate PCNA func-
tion in Xenopus egg extracts. Exp. Cell Res. 265:242–251.
Miyachi, K., M.J. Fritzler, and E.M. Tan. 1978. Autoantibody to a nuclear anti-
gen in proliferating cells. J. Immunol. 121:2228–2234.
Naryzhny, S.N., and H. Lee. 2004. The post-translational modifications of
proliferating cell nuclear antigen: acetylation, not phosphorylation,
plays an important role in the regulation of its function. J. Biol. Chem.
279:20194–20199.
Papouli, E., S. Chen, A.A. Davies, D. Huttner, L. Krejci, P. Sung, and H.D. Ul-
rich. 2005. Crosstalk between SUMO and ubiquitin on PCNA is medi-
ated by recruitment of the helicase Srs2p. Mol. Cell. 19:123–133.
Pfander, B., G.L. Moldovan, M. Sacher, C. Hoege, and S. Jentsch. 2005.
SUMO-modified PCNA recruits Srs2 to prevent recombination during
S phase. Nature. 436:428–433.
Prelich, G., C.K. Tan, M. Kostura, M.B. Mathews, A.G. So, K.M. Downey, and
B. Stillman. 1987. Functional identity of proliferating cell nuclear antigen
and a DNA polymerase-delta auxiliary protein. Nature. 326:517–520.
Prosperi, E., L.A. Stivala, E. Sala, A.I. Scovassi, and L. Bianchi. 1993. Prolifer-
ating cell nuclear antigen complex formation induced by ultraviolet irra-
diation in human quiescent fibroblasts as detected by immunostaining
and flow cytometry. Exp. Cell Res. 205:320–325.
Prosperi, E., A.I. Scovassi, L.A. Stivala, and L. Bianchi. 1994. Proliferating cell
nuclear antigen bound to DNA synthesis sites: phosphorylation and asso-
ciation with cyclin D1 and cyclin A. Exp. Cell Res. 215:257–262.
Schurtenberger, P., S.U. Egelhaaf, R. Hindges, G. Maga, Z.O. Jonsson, R.P.
May, O. Glatter, and U. Hubscher. 1998. The solution structure of func-
tionally active human proliferating cell nuclear antigen determined by
small-angle neutron scattering. J. Mol. Biol. 275:123–132.
Shivji, K.K., M.K. Kenny, and R.D. Wood. 1992. Proliferating cell nuclear anti-
gen is required for DNA excision repair. Cell. 69:367–374.
Stelter, P., and H.D. Ulrich. 2003. Control of spontaneous and damage-induced
mutagenesis by SUMO and ubiquitin conjugation. Nature. 425:188–191.
Tom, S., L.A. Henricksen, and R.A. Bambara. 2000. Mechanism whereby pro-
liferating cell nuclear antigen stimulates flap endonuclease 1. J. Biol.
Chem. 275:10498–10505.
Waga, S., G. Bauer, and B. Stillman. 1994. Reconstitution of complete SV40
DNA replication with purified replication factors. J. Biol. Chem. 269:
10923–10934.
Walter, J., and J. Newport. 1999. The use of Xenopus laevis interphase egg ex-
tracts to study genomic DNA replication. In Eukaryotic DNA Replication:
A Practical Approach. Sue Cotterill, editor. Oxford University Press.
201–222.
Watanabe, K., S. Tateishi, M. Kawasuji, T. Tsurimoto, H. Inoue, and M. Yamai-
zumi. 2004. Rad18 guides poleta to replication stalling sites through phys-
ical interaction and PCNA monoubiquitination. EMBO J. 23:3886–3896.